ARTICLE | Company News
Oxford GlycoSciences and Bayer in proteomics deal
March 9, 2000 8:00 AM UTC
Oxford GlycoSciences (LSE:OGS) will apply its proteomics technology to identify disease-associated proteins for Bayer (DAX:BAYG) as potential targets for drug development to treat asthma and chronic o...